Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 22, 2026
Align Technology (ALGN) to Report Q1 Earnings: What's in Store?
01:53pm, Wednesday, 22'nd Apr 2020
Align Technology (ALGN) is expected to have gained from continued adoption of Invisalign system in the first two months of Q1.
Align Technology (ALGN) to Report Q1 Earnings: What's in Store?
01:53pm, Wednesday, 22'nd Apr 2020
Align Technology (ALGN) is expected to have gained from continued adoption of Invisalign system in the first two months of Q1.
Can Diagnostics Aid Hologic (HOLX) Q2 Sales Amid Coronavirus?
01:40pm, Wednesday, 22'nd Apr 2020
Strength in segmental businesses is likely to have aided Hologic's (HOLX) performance in second-quarter fiscal 2020 amid the coronavirus-led economic doldrums.
Can Diagnostics Aid Hologic (HOLX) Q2 Sales Amid Coronavirus?
01:40pm, Wednesday, 22'nd Apr 2020
Strength in segmental businesses is likely to have aided Hologic's (HOLX) performance in second-quarter fiscal 2020 amid the coronavirus-led economic doldrums.
Exact Sciences Reports 63% Reduction For Cologuard Testing in April
09:20am, Wednesday, 22'nd Apr 2020
Exact Sciences (EXAS) has pre-announced first quarter results, with total revenue up 114% year-over-year at $348 million, surpassing the Street estimate of $342.6 million.The company, which focuses on
Exact Sciences (EXAS) Gets a Buy Rating from Oppenheimer
12:31am, Wednesday, 22'nd Apr 2020
In a report released yesterday, Kevin DeGeeter from Oppenheimer assigned a Buy rating to Exact Sciences (EXAS), with a price target of $115.00. The
Exact Sciences (EXAS) Gets a Buy Rating from Oppenheimer
12:31am, Wednesday, 22'nd Apr 2020
In a report released yesterday,
Kevin DeGeeter
from Oppenheimer assigned a
Buy
rating to Exact Sciences (
EXAS
–
Research Report
), with a price target of
$115.00
. The company’s shares closed las
Exact Sciences: This Cancer Diagnostics Stock Is Cheap Enough To Buy In 2020
09:27pm, Monday, 20'th Apr 2020
Exact Sciences is a leading player in tissue and liquid-based minimally invasive cancer diagnostics space. The company has robust financial profile. Investors s
Guggenheim Capital LLC Purchases 14,554 Shares of EXACT Sciences Co. (NASDAQ:EXAS)
12:32pm, Sunday, 19'th Apr 2020
Guggenheim Capital LLC increased its stake in EXACT Sciences Co. (NASDAQ:EXAS) by 29.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchang
Allworth Financial LP Takes $116,000 Position in EXACT Sciences Co. (NASDAQ:EXAS)
09:12am, Sunday, 19'th Apr 2020
Allworth Financial LP bought a new stake in EXACT Sciences Co. (NASDAQ:EXAS) in the 1st quarter, according to its most recent 13F filing with the SEC. The firm bought 2,000 shares of the medical resea
EXACT Sciences (NASDAQ:EXAS) Downgraded by ValuEngine
05:48am, Friday, 17'th Apr 2020
EXACT Sciences (NASDAQ:EXAS) was downgraded by ValuEngine from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Friday, ValuEngine reports. Several other broke
Exchange Traded Concepts LLC Acquires 1,239 Shares of EXACT Sciences Co. (NASDAQ:EXAS)
12:06pm, Thursday, 16'th Apr 2020
Exchange Traded Concepts LLC grew its holdings in EXACT Sciences Co. (NASDAQ:EXAS) by 116.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 2,3
2 Stocks That Could Double Your $1,200 Stimulus Check
10:15am, Thursday, 16'th Apr 2020
These two companies have exciting growth opportunities ahead and could make your money work for you.
Gofen & Glossberg LLC IL Sells 150 Shares of EXACT Sciences Co. (NASDAQ:EXAS)
09:53am, Thursday, 16'th Apr 2020
Gofen & Glossberg LLC IL lessened its holdings in EXACT Sciences Co. (NASDAQ:EXAS) by 1.9% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fi
EXACT Sciences Co. (NASDAQ:EXAS) Shares Sold by Artemis Investment Management LLP
09:17am, Thursday, 16'th Apr 2020
Artemis Investment Management LLP trimmed its position in shares of EXACT Sciences Co. (NASDAQ:EXAS) by 21.5% in the first quarter, HoldingsChannel reports. The firm owned 115,748 shares of the medica
